Chemed Corporation
General ticker "CHE" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $6.0B (TTM average)
Chemed Corporation follows the US Stock Market performance with the rate: 37.3%.
Estimated limits based on current volatility of 1.1%: low 505.02$, high 516.39$
Factors to consider:
- Earnings expected soon, date: 2026-10-27 amc
- Company pays dividends (quarterly): last record date 2026-08-17, amount 0.70$ (Y0.55%)
- Total employees count: 15811 (+0.7%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Market competition, Regulatory and compliance, Cybersecurity threats, Labor/talent shortage/retention, Hurricane damage
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [353.73$, 516.14$]
- 2026-12-31 to 2027-12-31 estimated range: [371.27$, 534.25$]
Financial Metrics affecting the CHE estimates:
- Negative: with PPE of 20.0 at the end of fiscal year the price was high
- Positive: 11.29 < Operating profit margin, % of 13.38
- Positive: 4.90 < Operating cash flow per share per price, % of 6.23
- Positive: -1.23 < Investing cash flow per share per price, % of -0.95
- Positive: -4.55 < Industry operating profit margin (median), % of -0.34
- Negative: 58.56 < Shareholder equity ratio, % of 63.67 <= 69.38
- Positive: Return on assets ratio (scaled to [-100,100]) of 14.71 > 10.70
- Positive: Inventory ratio change, % of -0.04 <= 0
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: 0 < Industry inventory ratio change (median), % of 0
Short-term CHE quotes
Long-term CHE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,262.16MM | $2,430.84MM | $2,527.07MM |
| Operating Expenses | $1,921.59MM | $2,064.35MM | $2,188.82MM |
| Operating Income | $340.57MM | $366.49MM | $338.25MM |
| Non-Operating Income | $9.80MM | $32.97MM | $17.53MM |
| Interest Expense | $3.11MM | $1.78MM | $1.75MM |
| Income(Loss) | $350.37MM | $399.46MM | $355.78MM |
| Taxes | $77.86MM | $97.47MM | $90.54MM |
| Net Income(Loss)* | $272.51MM | $302.00MM | $265.24MM |
| Stockholders Equity | $1,107.88MM | $1,118.99MM | $979.40MM |
| Inventory | $12.00MM | $8.19MM | $7.54MM |
| Assets | $1,668.10MM | $1,668.58MM | $1,538.19MM |
| Operating Cash Flow | $330.30MM | $417.50MM | $388.27MM |
| Capital expenditure | $56.85MM | $49.53MM | $62.80MM |
| Investing Cash Flow | $-60.64MM | $-143.91MM | $-59.34MM |
| Financing Cash Flow | $-79.83MM | $-359.19MM | $-432.77MM |
| Earnings Per Share** | $18.11 | $20.10 | $18.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.